Avantis International Equity ETF
American Century ETF Trust · Series S000066456 · 1 share classes
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2025 Q4
The fund seeks long-term capital appreciation.
The fund actively selects non-U.S. equities across all market capitalizations, with an emphasis on smaller companies that exhibit higher profitability and attractive value characteristics, as measured by adjusted book-to-price and cash-flow-to-book ratios; it underweights or excludes larger companies with lower profitability and less attractive valuations. Security weightings are based on market capitalization as a baseline, then adjusted up or down according to these characteristics and other factors including past performance, liquidity, and governance. Because security selection depends on the portfolio managers' assessment of profitability and value metrics that may prove incorrect, fund performance will diverge from broad non-U.S. equity benchmarks.
| Share class | Expense ratio |
|---|---|
| AVDE | 0.23% |
Portfolio turnover 3.00% · as of 2025 Q4
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 99.75% |
| Cash & short-term | 1.74% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: AstraZeneca PLC, TotalEnergies SE, Reckitt Benckiser Group PLC, Unilever PLC, Zealand Pharma A/S, QIAGEN NV, Discovery Silver Corp, OVV
Largest exited: TotalEnergies SE, AstraZeneca PLC, Reckitt Benckiser Group PLC, Unilever PLC, Baloise Holding AG, Telefonica SA, Covestro AG, QIAGEN NV
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| — | State Street Navigator Securities Lending Trust - State Street Navigator Securities Lending Government Money Market Portfolio | 1.57% | $235.85M | — |
| — | ASML Holding NV | 1.15% | $172.96M | 119.2K |
| — | Roche Holding AG | 1.00% | $150.56M | 316.4K |
| HSBC | HSBC Holdings PLCHSBC | 0.84% | $126.45M | 1.4M |
| SHEL | Shell PLCSHEL | 0.81% | $121.28M | 1.5M |
| NVS | Novartis AGNVS | 0.67% | $101.13M | 599.7K |
| TM | Toyota Motor CorpTM | 0.57% | $86.46M | 356.7K |
| — | Safran SA | 0.57% | $86.15M | 213.9K |
| AZN | AstraZeneca PLCAZN | 0.57% | $85.09M | 408.2K |
| AEM | Agnico Eagle Mines LtdAEM | 0.53% | $79.77M | 317.6K |
Top 10 positions are 8.29% of net assets, top 25 14.72%, across 3.3K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free